| CH621479A5 (en)* | 1977-08-05 | 1981-02-13 | Battelle Memorial Institute | |
| IT1110989B (en)* | 1979-01-19 | 1986-01-13 | Erba Farmitalia | PHARMACEUTICAL FORMS CONSTITUTED BY LIPOSOMES AND RELATED PROCEDURES |
| FR2416008A1 (en)* | 1978-02-02 | 1979-08-31 | Oreal | LIPOSOME LYOPHILISATES |
| IT1111367B (en)* | 1978-11-17 | 1986-01-13 | Serono Ist Farm | PROCESS FOR THE ETHERPORARY PREPARATION OF LIPOSOMES AND LIPOSOMES SO OBTAINED |
| JPS55118415A (en)* | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
| DE2914789A1 (en)* | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | INJECTABLE MEDICINES WITH ANTI-INFLAMMATORY EFFECT |
| DE2914788A1 (en)* | 1979-04-11 | 1980-10-16 | Nattermann A & Cie | PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT |
| JPS55153713A (en)* | 1979-05-02 | 1980-11-29 | Kureha Chem Ind Co Ltd | Pharmaceutical preparation of ribosome containing active substance |
| CA1173360A (en) | 1979-06-22 | 1984-08-28 | Jurg Schrank | Pharmaceutical preparations |
| US4310505A (en)* | 1979-11-08 | 1982-01-12 | California Institute Of Technology | Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances |
| HU184141B (en)* | 1979-12-27 | 1984-07-30 | Human Oltoanyagtermelo | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
| JPS5775916A (en)* | 1980-10-29 | 1982-05-12 | Nippon Chemiphar Co Ltd | Coenzyme q pharmaceutical and its preparation |
| JPS57146710A (en)* | 1981-03-07 | 1982-09-10 | Kunio Yagi | Blood brain-barrier permeating ribosome-like microcapsule |
| US4397846A (en)* | 1981-05-15 | 1983-08-09 | Murray Weiner | Storage-stable lipid vesicles and method of preparation |
| JPS58128318A (en)* | 1982-01-22 | 1983-07-30 | フアイソンズ・ピ−エルシ− | Pharmaceutical composition |
| JPS58222014A (en)* | 1982-06-18 | 1983-12-23 | Taisho Pharmaceut Co Ltd | Prostaglandin E↓1 fat emulsion |
| US4588578A (en)* | 1983-08-08 | 1986-05-13 | The Liposome Company, Inc. | Lipid vesicles prepared in a monophase |
| GB8322178D0 (en)* | 1983-08-17 | 1983-09-21 | Sterwin Ag | Preparing aerosol compositions |
| US4744989A (en)* | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
| US5141674A (en)* | 1984-03-08 | 1992-08-25 | Phares Pharmaceutical Research N.V. | Methods of preparing pro-liposome dispersions and aerosols |
| JPS60208910A (en)* | 1984-03-31 | 1985-10-21 | Green Cross Corp:The | Preparation of composite of hardly water-soluble drug and phospholipid |
| SE8403905D0 (en)* | 1984-07-30 | 1984-07-30 | Draco Ab | LIPOSOMES AND STEROID ESTERS |
| US4880635B1 (en)* | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US5736155A (en)* | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| US5077056A (en)* | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| EP0172007B1 (en)* | 1984-08-10 | 1991-05-22 | Syntex (U.S.A.) Inc. | Stable liposomes with aqueous-soluble medicaments and methods for their preparation |
| JPS6150912A (en)* | 1984-08-16 | 1986-03-13 | Shionogi & Co Ltd | Production of liposome preparation |
| JPS61100518A (en)* | 1984-10-22 | 1986-05-19 | Ono Pharmaceut Co Ltd | Lyophilized ribosome pharmaceutical preparation comprising dimyristoylphosphatidylcholine as main component |
| US4857319A (en)* | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
| US4830858A (en)* | 1985-02-11 | 1989-05-16 | E. R. Squibb & Sons, Inc. | Spray-drying method for preparing liposomes and products produced thereby |
| US5409704A (en)* | 1985-06-26 | 1995-04-25 | The Liposome Company, Inc. | Liposomes comprising aminoglycoside phosphates and methods of production and use |
| FR2591105B1 (en)* | 1985-12-11 | 1989-03-24 | Moet Hennessy Rech | PHARMACEUTICAL COMPOSITION, IN PARTICULAR DERMATOLOGICAL, OR COSMETIC, BASED ON HYDRATED LIPID LAMELLAR PHASES OR LIPOSOMES CONTAINING A RETINOIDE OR A STRUCTURAL ANALOG OF SUCH A RETINOID AS A CAROTENOID. |
| US5068198A (en)* | 1986-03-26 | 1991-11-26 | Syntex (U.S.A.) Inc. | Liquid single reagent for assays involving confining gels |
| SE8601457D0 (en)* | 1986-04-01 | 1986-04-01 | Draco Ab | COMPOSITIONS OF LIPOSOMES AND B? 712 RECEPTOR ACTIVE SUBSTANCES FOR INHALATION |
| FR2597345B1 (en)* | 1986-04-22 | 1990-08-03 | Oreal | COSMETIC OR PHARMACEUTICAL COMPOSITION BASED ON AN AQUEOUS DISPERSION OF LIPID SPHERULES. |
| SE8603812D0 (en)* | 1986-09-12 | 1986-09-12 | Draco Ab | ADMINISTRATION OF LIPOSOMES TO MAMMALS |
| US4891324A (en)* | 1987-01-07 | 1990-01-02 | Syntex (U.S.A.) Inc. | Particle with luminescer for assays |
| US5089181A (en)* | 1987-02-24 | 1992-02-18 | Vestar, Inc. | Method of dehydrating vesicle preparations for long term storage |
| US5811119A (en)* | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
| WO1988009170A1 (en)* | 1987-05-22 | 1988-12-01 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
| US5262168A (en)* | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
| US5925375A (en)* | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
| US4963362A (en)* | 1987-08-07 | 1990-10-16 | Regents Of The University Of Minnesota | Freeze-dried liposome mixture containing cyclosporin |
| US5178875A (en)* | 1991-01-14 | 1993-01-12 | The Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
| US4950432A (en)* | 1987-10-16 | 1990-08-21 | Board Of Regents, The University Of Texas System | Polyene microlide pre-liposomal powders |
| US5830498A (en)* | 1987-10-16 | 1998-11-03 | Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
| US4981690A (en)* | 1987-10-27 | 1991-01-01 | Board Of Regents, The University Of Texas System | Liposome-incorporated mepartricin |
| JPH0610131B2 (en)* | 1987-10-30 | 1994-02-09 | テルモ株式会社 | Liposomal manufacturing method |
| WO1989006977A1 (en)* | 1988-02-04 | 1989-08-10 | Board Of Regents, The University Of Texas System | Formulation and use of retinoids in treatment of cancer and other diseases |
| US5096629A (en)* | 1988-08-29 | 1992-03-17 | 501 Nippon Fine Chemical Co., Ltd. | Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes |
| JP2955314B2 (en)* | 1988-10-27 | 1999-10-04 | リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ | IL-2 containing liposome immunoadjuvant |
| US5174988A (en)* | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
| USRE39146E1 (en) | 1990-04-02 | 2006-06-27 | Bracco International B.V. | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| US6613306B1 (en) | 1990-04-02 | 2003-09-02 | Bracco International B.V. | Ultrasound contrast agents and methods of making and using them |
| US5445813A (en)* | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
| US20040208826A1 (en)* | 1990-04-02 | 2004-10-21 | Bracco International B.V. | Ultrasound contrast agents and methods of making and using them |
| US5578292A (en) | 1991-11-20 | 1996-11-26 | Bracco International B.V. | Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| US20010024638A1 (en)* | 1992-11-02 | 2001-09-27 | Michel Schneider | Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof |
| US7083778B2 (en)* | 1991-05-03 | 2006-08-01 | Bracco International B.V. | Ultrasound contrast agents and methods of making and using them |
| US6989141B2 (en)* | 1990-05-18 | 2006-01-24 | Bracco International B.V. | Ultrasound contrast agents and methods of making and using them |
| IN172208B (en)* | 1990-04-02 | 1993-05-01 | Sint Sa | |
| AU636481B2 (en)* | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| US20030194376A1 (en)* | 1990-05-18 | 2003-10-16 | Bracco International B.V. | Ultrasound contrast agents and methods of making and using them |
| DE69120089T2 (en)* | 1990-07-31 | 1996-12-12 | Liposome Co Inc | Accumulation of amino acids and peptides in liposomes |
| US5340716A (en)* | 1991-06-20 | 1994-08-23 | Snytex (U.S.A.) Inc. | Assay method utilizing photoactivated chemiluminescent label |
| US6251581B1 (en) | 1991-05-22 | 2001-06-26 | Dade Behring Marburg Gmbh | Assay method utilizing induced luminescence |
| US5885260A (en)* | 1991-05-30 | 1999-03-23 | Mehl, Sr.; Thomas L. | Freeze-dried liposome delivery system for application of skin treatment agents |
| WO1992022298A1 (en)* | 1991-06-18 | 1992-12-23 | Unger Evan C | Novel liposomal drug delivery systems |
| FR2681781A1 (en)* | 1991-09-30 | 1993-04-02 | Oreal | ANHYDROUS COSMETIC COMPOSITION COMPRISING A FATTY PHASE AND COSMETIC TREATMENT METHOD USING THE SAME. |
| CA2127107C (en)* | 1991-12-31 | 2007-06-19 | Bruce L. A. Carter | Methods and compositions for reducing blood loss |
| IL104084A (en)* | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them |
| US5736141A (en)* | 1992-06-05 | 1998-04-07 | Dalhousie University | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant |
| USRE37224E1 (en)* | 1992-06-05 | 2001-06-12 | Dalhousie University | Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant |
| ATE162892T1 (en)* | 1992-07-31 | 1998-02-15 | Behringwerke Ag | PHOTOACTIVABLE CHEMILUMINIZING MATRICES |
| DE4309579C3 (en)* | 1993-03-24 | 2000-01-27 | Sanol Arznei Schwarz Gmbh | Pharmaceutical composition in the form of a pack |
| ES2115343T3 (en)* | 1993-11-05 | 1998-06-16 | Amgen Inc | METHOD OF PREPARATION OF LIPOSOMES AND ENCAPSULATION OF MATERIAL. |
| PL182223B1 (en)* | 1993-12-15 | 2001-11-30 | Bracco Research Sa | Biocompatible dispersion phase for ultrasound contrast agent preparation, ultrasound contrast agent, dry contrast agent preparation and two-component ultrasound contrast agent kit PL EN EN |
| IT1269569B (en)* | 1994-04-22 | 1997-04-08 | Ugo Citernesi | PROCEDURE FOR THE PREPARATION OF COMPLEX BETWEEN PHOSPHOLIPIDS AND ACTIVE PRINCIPLES USEFUL FOR THE PRODUCTION OF LIPOSOMES AND ACTIVE PRINCIPLES AND LIPOSOMES OBTAINED WITH THE PROCEDURE |
| US6156337A (en)* | 1994-07-08 | 2000-12-05 | Opperbas Holding B.V. | Method for high loading of vesicles with biopolymeric substances |
| IL115099A (en)* | 1994-10-14 | 1999-04-11 | Upjohn Co | Lyophilizate of phospholipid complex of water insoluble camptothecins |
| US5834428A (en)* | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US5990077A (en) | 1995-04-14 | 1999-11-23 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US6184201B1 (en) | 1995-04-14 | 2001-02-06 | Nps Allelix Corp. | Intestinotrophic glucagon-like peptide-2 analogs |
| US5902604A (en)* | 1995-06-06 | 1999-05-11 | Board Of Regents, The University Of Texas System | Submicron liposome suspensions obtained from preliposome lyophilizates |
| DE69716905T2 (en) | 1996-04-12 | 2003-07-24 | 1149336 Ontario Inc., Toronto | ANALOGS OF THE GLUCAGON-LIKE PEPTIDES -2 |
| US6111081A (en)* | 1996-05-31 | 2000-08-29 | Baylor College Of Medicine | Lactoferrin variants and uses thereof |
| MY127839A (en)* | 1996-10-25 | 2006-12-29 | Monsanto Technology Llc | Compositions and method for treating plants with exogenous chemicals |
| ES2194190T3 (en) | 1996-10-25 | 2003-11-16 | Monsanto Technology Llc | COMPOSITION AND PROCEDURE TO TREAT PLANTS WITH EXOGENOUS CHEMICALS. |
| US6037125A (en)* | 1996-11-05 | 2000-03-14 | Lexicon Genetics Incorporated | Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells |
| CA2236519C (en) | 1997-05-02 | 2011-09-13 | 1149336 Ontario Inc. | Methods of enhancing functioning of the large intestine |
| RU2130771C1 (en)* | 1998-06-01 | 1999-05-27 | Автушенко Сергей Сергеевич | Method of preparing liposomal preparations |
| CN1531424A (en)* | 2000-11-09 | 2004-09-22 | ����˹��ҩ�﹫˾ | SN-38 lipid complexes and methods of use |
| ATE319428T1 (en)* | 2000-12-07 | 2006-03-15 | Univ Utrecht Holding Bv | COMPOSITION FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| WO2003030864A1 (en)* | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
| US6939564B2 (en)* | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| US6780324B2 (en)* | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| US20040082521A1 (en)* | 2002-03-29 | 2004-04-29 | Azaya Therapeutics Inc. | Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| US20030212046A1 (en)* | 2002-05-07 | 2003-11-13 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
| US20060093661A1 (en) | 2002-05-07 | 2006-05-04 | Kapac, Llc | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |
| US20050152962A1 (en)* | 2002-06-12 | 2005-07-14 | Metselaar Josbert M. | Composition for treatment of inflammatory disorders |
| US20060030578A1 (en)* | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
| AU2003296897A1 (en)* | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
| EP1393720A1 (en)* | 2002-08-27 | 2004-03-03 | Universiteit Utrecht | Vesicle-encapsulated corticosteroids for treatment of cancer |
| KR100651728B1 (en)* | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | Compound for an electronic device having a fixing group, an electronic device comprising the same and a method of manufacturing the same |
| US20060198891A1 (en)* | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
| WO2006071659A1 (en)* | 2004-12-29 | 2006-07-06 | Trustees Of Boston University | Delivery of h2 antagonists |
| WO2006108637A2 (en) | 2005-04-13 | 2006-10-19 | Abbott Gmbh & Co.Kg | Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof |
| DE102005017777A1 (en)* | 2005-04-13 | 2006-10-19 | Pharmasol Gmbh | Preparation of high fine particle suspension comprises dissolving solid in a solvent, freezing, lyophilizing solid matrix, withdrawing solid matrix from solvent and dispersing in an external phase and applying high power on the dispersion |
| EP2081548A2 (en)* | 2006-09-22 | 2009-07-29 | Labopharm Inc. | Compositions and methods for ph targeted drug delivery |
| US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
| EP2555791B1 (en) | 2010-04-09 | 2017-11-01 | Sinai Health System | Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist |
| CA2834968C (en) | 2011-01-05 | 2018-01-09 | Livon Laboratories | Methods of making liposomes, liposome compositions made by the methods, and methods of using the same |
| WO2015006228A1 (en) | 2013-07-08 | 2015-01-15 | The University Of Utah Research Foundation | Methods for treatment of and prophylaxis against inflammatory disorders |
| US10772926B2 (en) | 2016-12-16 | 2020-09-15 | Nutragen Health Innovations, Inc. | Natural drugs for the treatment of inflammation and melanoma |
| WO2018204918A1 (en) | 2017-05-05 | 2018-11-08 | Ardelyx, Inc. | Treatment of hepatic disorders |
| JP2021518401A (en) | 2018-03-21 | 2021-08-02 | コロラド ステート ユニバーシティー リサーチ ファウンデーション | Cancer vaccine composition and how to use it |
| RU2740553C2 (en)* | 2019-01-30 | 2021-01-15 | Анастасия Андреевна Карбаинова | Method of producing liposomal form of betulin, having hepatoprotective activity |
| LT6699B (en) | 2019-07-15 | 2020-02-10 | UAB "Valentis" | Method for production of proliposomes by using up to 5% ethanol and the use thereof for encapsulation of lipophilic substances |
| WO2021178877A1 (en) | 2020-03-06 | 2021-09-10 | The Colorado State University Research Foundation | Production of vaccines comprising inactivated sars-cov-2 viral particles |
| KR20230058399A (en) | 2020-07-28 | 2023-05-03 | 재즈 파마슈티칼즈 아일랜드 리미티드 | Fused bicyclic RAF inhibitors and methods of use thereof |
| KR20230058630A (en) | 2020-07-28 | 2023-05-03 | 재즈 파마슈티칼즈 아일랜드 리미티드 | Chiral synthesis of fused bicyclic RAF inhibitors |
| EP4312536A1 (en) | 2021-04-01 | 2024-02-07 | Vestaron Corporation | Liposome formulations for pesticide delivery and methods for producing and using the same |
| CA3238764A1 (en) | 2021-11-23 | 2023-06-01 | Siddharth Patel | A bacteria-derived lipid composition and use thereof |
| WO2024159172A1 (en) | 2023-01-27 | 2024-08-02 | Senda Biosciences, Inc. | A modified lipid composition and uses thereof |